2 value stocks to consider in an expensive market: Indivior plc and Impellam Group plc

Should you buy Indivior plc (LON:INDV) and Impellam Group plc (LON:IPEL) as value plays following today’s announcements?

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Shares in pharmaceutical company Indivior (LSE: INDV) soared more than 16% at one point on Thursday after management upped its outlook for revenue and earnings for the full year.

Due to unexpectedly strong market conditions and market share resilience of its Suboxone film product, net revenue for the 2017 full year is now expected to be in a range of $1.09bn to $1.12bn, a target which tops its previous guidance of $1.05bn to $1.08bn. Additionally, adjusted net income is now forecast to rise to $265m to $285m, well above its previous guidance of $200m to $220m, because of expected lower legal and R&D costs.

Meanwhile, the company is making significant progress with its development pipeline. It is set to launch new trials and is moving closer to bringing new treatments to market. This should help to underpin additional growth in future years, while reduced costs could lift margins. 

Indivior, which focuses on specialist anti-addiction medicines, was spun-off from consumer goods group Reckitt Benckiser back in 2014. And ever since its demerger, the share price has been plagued by concerns about patent issues and litigation costs. Following today’s guidance however, I reckon these risks may have been overstated.

It remains attractively valued as it trades on a price-to-earnings ratio of 10.3 — and this suggests shares in the company could have considerable upside potential as investor sentiment looks set to improve.

Impellam

Also reporting today was recruitment and staffing solutions specialist Impellam (LSE: IPEL). Shares in the company fell by as much as 8% today, as investors contrasted its fortunes with those of its rivals.

Although first-half revenues grew in line with peers, with an increase of 2.4% to £1.08bn in the six months to 30 June, operating profits fell 30% to £15.4m. This was on the back of challenging trading conditions, the impact of off-payroll working legislation (IR35) in the UK Doctors and Nursing market, and increased investment.

It’s never good to see profits fall, but I remain somewhat upbeat about the group’s long-term prospects. Certainly, the company is some way off its best and it is likely to take years rather than months before it returns to being so, but Impellam’s problems have mainly been isolated to its UK healthcare business. Trading elsewhere, particularly outside of the UK, has been much more favourable, and the group has a strong pipeline of client implementations ahead.

Reassuringly, its cash generation also remains good. Net debt fell from £95.3m to £92.1m, while cash generation dropped by less than 5% to £21.9m. And despite its near-term earnings weakness, management stuck to its stated policy of keeping dividend cover at between four to five times adjusted earnings per share, and kept its interim dividend at 7p per share.

And since Impellam trades on a price-to-earnings ratio of just eight, it seems to offer excellent value for money. What’s more, its yield of 3% marks it out as a tempting income play.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Jack Tang has no position in any shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Young black colleagues high-fiving each other at work
Investing Articles

Here’s why the Haleon share price jumped 6% higher today

As the Haleon share price rises, our writer considers whether he should add this consumer healthcare stock to his portfolio.

Read more »

Smart young brown businesswoman working from home on a laptop
Investing Articles

Last-minute ISA buys! 2 dirt-cheap dividend stocks I’d grab before April’s deadline

Aviva and Greencoat UK Wind shares look stunningly cheap at current prices. Here Royston Wild explains why he's looking to…

Read more »

Young happy white woman loading groceries into the back of her car
Investing Articles

Should I buy, as the Ocado share price perks up on FY results?

The Ocado share price is steady, as the online retail giant reports a big fall in 2023 losses. Is it…

Read more »

Illustration of flames over a black background
Investing Articles

Here’s another top buy from the FTSE 250 I’m considering

Oliver Rodzianko considers this FTSE 250 company a stellar choice for his portfolio. It's on his growth watchlist; so let's…

Read more »

A young Asian woman holding up her index finger
Investing Articles

A “once in a lifetime” opportunity for Rolls-Royce shares?

One firm is hoping now is a “once in a lifetime” opportunity for UK nuclear companies. Our writer reveals whether…

Read more »

Young Black woman looking concerned while in front of her laptop
Investing Articles

The IAG share price is dirt cheap and profits are flying. So why am I worried?

After today's positive full-year results, I expected the International Consolidated Airlines Group (IAG) share price to be doing better than…

Read more »

Investing Articles

Is Tesla stock a steal below $200?

Tesla stock has fallen 19% so far in 2024. Currently hovering around $200, this Fool checks if now is the…

Read more »

Investing Articles

3 high-yield dividend stocks to consider for my passive income portfolio in 2024

I want to build a portfolio of dividend stocks that pay enough passive income to retire comfortably. Here are my…

Read more »